Medical Science Liaison / Senior Medical Science Liaison
Acadia Pharmaceuticals- Full Time
- Junior (1 to 2 years)
Employment Type: Full-time Location Type: Remote (USA) Salary: $130,600 - $165,000 USD
Natera is seeking a remote Medical Science Liaison (MSL) to join our Medical Affairs team during a critical pre-launch phase for our novel cancer diagnostic assays. As a key scientific ambassador, the MSL will be responsible for building strong relationships with primary care and oncology experts, communicating scientific evidence, gathering field insights, supporting clinical trials, and preparing for a successful launch. This role demands deep scientific knowledge, exceptional communication skills, and the ability to thrive in a dynamic, fast-paced start-up environment.
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
The Natera team consists of highly dedicated statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers, and many other professionals from world-class institutions, who care deeply for our work and each other. When you join Natera, you’ll work hard and grow quickly. Working alongside the elite of the industry, you’ll be stretched and challenged, and take pride in being part of a company that is making a significant impact on patient lives.
Note: The pay range listed is a general guideline. Actual compensation packages are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications, and specific office location. This may differ in other locations due to cost of labor considerations.
Genetic testing and diagnostics solutions provider
Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.